These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Applying value-based strategies to accelerate access to novel cancer medications: guidance from the Oncology Health Economics Expert Panel in Qatar (Q-OHEP). Hamad A; Elazzazy S; Bujassoum S; Rasul K; Gaziev J; Cherif H; Al-Boloshi Z; Hanssens Y; Saleh A; Rasheed HA; Al-Badriyeh D; Babiker A; Hmaidan AA; Al-Hail M BMC Health Serv Res; 2023 Jan; 23(1):15. PubMed ID: 36609388 [TBL] [Abstract][Full Text] [Related]
4. The FDA Oncology Center of Excellence and precision medicine. Goldberg KB; Blumenthal GM; McKee AE; Pazdur R Exp Biol Med (Maywood); 2018 Feb; 243(3):308-312. PubMed ID: 29105511 [TBL] [Abstract][Full Text] [Related]
5. International Society for Cell and Gene Therapy of Cancer 2009 Annual Meeting held in Cork, Ireland. Guinn B; Casey G; Möller MG; Kasahara N; O'Sullivan GC; Peng KW; Tangney M Hum Gene Ther; 2010 Jan; 21(1):9-26. PubMed ID: 20017714 [TBL] [Abstract][Full Text] [Related]
6. [Development of antituberculous drugs: current status and future prospects]. Tomioka H; Namba K Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921 [TBL] [Abstract][Full Text] [Related]
7. Challenging Standard-of-Care Paradigms in the Precision Oncology Era. Subbiah V; Kurzrock R Trends Cancer; 2018 Feb; 4(2):101-109. PubMed ID: 29458960 [TBL] [Abstract][Full Text] [Related]
8. Personalized Oncology Meets Immunology: The Path toward Precision Immunotherapy. Mandal R; Chan TA Cancer Discov; 2016 Jul; 6(7):703-13. PubMed ID: 27107038 [TBL] [Abstract][Full Text] [Related]
9. The changing face of clinical trials in the personalized medicine and immuno-oncology era: report from the international congress on clinical trials in Oncology & Hemato-Oncology (ICTO 2017). Golan T; Milella M; Ackerstein A; Berger R J Exp Clin Cancer Res; 2017 Dec; 36(1):192. PubMed ID: 29282151 [TBL] [Abstract][Full Text] [Related]
10. The expanding role of the clinical haematologist in the new world of advanced therapy medicinal products. Lowdell MW; Thomas A Br J Haematol; 2017 Jan; 176(1):9-15. PubMed ID: 27748517 [TBL] [Abstract][Full Text] [Related]
11. The innovative evolution of cancer gene and cellular therapies. Lam P; Khan G; Stripecke R; Hui KM; Kasahara N; Peng KW; Guinn BA Cancer Gene Ther; 2013 Mar; 20(3):141-9. PubMed ID: 23370333 [TBL] [Abstract][Full Text] [Related]
12. Current Status of Gene Engineering Cell Therapeutics. Saudemont A; Jespers L; Clay T Front Immunol; 2018; 9():153. PubMed ID: 29459866 [No Abstract] [Full Text] [Related]
13. Prospects for personalized combination immunotherapy for solid tumors based on adoptive cell therapies and immune checkpoint blockade therapies. Kato D; Yaguchi T; Iwata T; Morii K; Nakagawa T; Nishimura R; Kawakami Y Nihon Rinsho Meneki Gakkai Kaishi; 2017; 40(1):68-77. PubMed ID: 28539557 [TBL] [Abstract][Full Text] [Related]
14. Systematic biobanking, novel imaging techniques, and advanced molecular analysis for precise tumor diagnosis and therapy: The Polish MOBIT project. Niklinski J; Kretowski A; Moniuszko M; Reszec J; Michalska-Falkowska A; Niemira M; Ciborowski M; Charkiewicz R; Jurgilewicz D; Kozlowski M; Ramlau R; Piwkowski C; Kwasniewski M; Kaczmarek M; Ciereszko A; Wasniewski T; Mroz R; Naumnik W; Sierko E; Paczkowska M; Kisluk J; Sulewska A; Cybulski A; Mariak Z; Kedra B; Szamatowicz J; Kurzawa P; Minarowski L; Charkiewicz AE; Mroczko B; Malyszko J; Manegold C; Pilz L; Allgayer H; Abba ML; Juhl H; Koch F; Adv Med Sci; 2017 Sep; 62(2):405-413. PubMed ID: 28646744 [TBL] [Abstract][Full Text] [Related]
15. Psychosocial Impact of Personalized Therapies in Oncology. Schilling G; Schulz-Kindermann F Recent Results Cancer Res; 2018; 210():181-190. PubMed ID: 28924686 [TBL] [Abstract][Full Text] [Related]
16. Gene and cell therapy for pancreatic cancer. Singh HM; Ungerechts G; Tsimberidou AM Expert Opin Biol Ther; 2015 Apr; 15(4):505-16. PubMed ID: 25582170 [TBL] [Abstract][Full Text] [Related]